Clementia Pharmaceuticals Inc.
(NASDAQ : CMTA)

( )
CMTA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
0.20%45.331.4%$886.97m
MRKMerck & Co., Inc.
1.55%74.600.6%$868.71m
PFEPfizer Inc.
1.13%39.420.9%$823.54m
JNJJohnson & Johnson
1.50%139.900.7%$815.75m
LLYEli Lilly and Company
1.74%117.481.0%$663.22m
ABBVAbbVie, Inc.
0.64%78.652.2%$407.28m
NVSNovartis AG Sponsored ADR
0.66%75.900.2%$278.63m
AZNAstraZeneca PLC Sponsored ADR
-0.16%38.691.3%$252.32m
GSKGlaxoSmithKline plc Sponsored ADR
1.34%40.210.2%$103.17m
NVONovo Nordisk A/S Sponsored ADR Class B
1.19%48.670.1%$67.15m
SNYSanofi Sponsored ADR
0.87%41.710.2%$36.01m
LCILannett Company, Inc.
-0.28%7.2036.7%$7.66m
AKTXAkari Therapeutics Plc Sponsored ADR
15.82%3.881.6%$5.73m
EPIXESSA Pharma Inc
-3.04%2.300.1%$0.03m

Company Profile

Clementia Pharmaceuticals, Inc. provides healthcare services. It is a biopharmaceutical company, which focuses on exploiting the science of novel retinoic acid receptor gamma agonists to address bone disease and involves in development and commercialization of treatments for people living with rare diseases. Clementia Pharmaceuticals was founded by Clarissa Desjardins and Jean-Claude Tardif on November 5, 2010 and is headquartered in Montreal, Canada.